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Abstract
Background: Long non-coding RNAs (lncRNAs) comprise a diverse class of transcripts that can regulate molecular
and cellular processes in brain development and disease. LncRNAs exhibit cell type- and tissue-specific expression,
but little is known about the expression and function of lncRNAs in the developing human brain. Furthermore, it
has been unclear whether lncRNAs are highly expressed in subsets of cells within tissues, despite appearing lowly
expressed in bulk populations.
Results: We use strand-specific RNA-seq to deeply profile lncRNAs from polyadenylated and total RNA obtained
from human neocortex at different stages of development, and we apply this reference to analyze the transcriptomes
of single cells. While lncRNAs are generally detected at low levels in bulk tissues, single-cell transcriptomics of hundreds
of neocortex cells reveal that many lncRNAs are abundantly expressed in individual cells and are cell type-specific.
Notably, LOC646329 is a lncRNA enriched in single radial glia cells but is detected at low abundance in tissues. CRISPRi
knockdown of LOC646329 indicates that this lncRNA regulates cell proliferation.
Conclusion: The discrete and abundant expression of lncRNAs among individual cells has important implications for
both their biological function and utility for distinguishing neural cell types.
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Background
Long non-coding RNAs (lncRNAs), transcripts longer
than 200 nt without protein coding potential, comprise
upwards of 58,000 genes in the human genome and have
important roles in neural development, function, and
disease [1–9]. LncRNAs exhibit tissue specific expres-
sion, with the brain producing an extraordinary number
and diversity of lncRNAs [4, 5, 10, 11]. Furthermore, in
the brain, lncRNAs have regionally segregated expres-
sion patterns [5, 12] and many lncRNAs are enriched in
specific sub-populations of the mouse [13] and human
[14] cortex. However, little is known about lncRNA ex-
pression and function in the developing human brain.
Current annotations of lncRNAs expressed in the hu-
man brain are incomplete, partly due to the use of polya-
denylated (polyA) transcript selection and RNA-seq
libraries that do not preserve strand information [15, 16].
As a result, non-polyadenylated lncRNAs and antisense
lncRNAs – several of which have known biological func-
tions [17–19] – remain poorly described. Furthermore,
the expression of lncRNAs in the human brain has not
been systematically analyzed at the single-cell level,
limiting our understanding of temporal- and cell type-
specific lncRNAs.
Bulk tissue studies have suggested that lncRNAs are
expressed, on average, at lower levels than mRNAs. It
has been unclear whether this is due to uniformly low
levels of lncRNAs in all cells, or due to high levels of
lncRNAs in subpopulations of cells. In the brain, the latter
explanation would suggest that lncRNAs, previously
thought to be transcriptional noise, might have highly spe-
cialized roles in the differentiation or function of specific
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cell types. While studies of cultured cells provide evidence
for both possibilities [20, 21], whether these observations
are consistent with the in vivo expression of lncRNAs in
cells within heterogeneous tissues – such as that of the de-
veloping human brain – has been not been determined.
Here, we combined bulk tissue RNA-seq and single-cell
RNA-seq to deeply profile lncRNA expression during neo-
cortical development. Both polyA selected and total RNA
were sequenced using strand-specific methods to compre-
hensively annotate and quantify lncRNAs in tissues. By
applying this reference transcriptome to single-cell RNA-
seq, we found that many lncRNAs are specific to distinct
cell types and are abundantly expressed in individual cells.
Furthermore, we found that the cell type-specific ex-
pression of lncRNAs contributes to the low levels of
lncRNAs observed in tissues. Finally, using CRISPRi
(clustered regularly interspaced short palindromic re-
peats interference) knockdown, we demonstrated that
LOC646329, a lncRNA that appears low in neocortical
tissues but high in the radial glia subpopulation, regu-
lates cell proliferation.
Results
Catalogue of long non-coding RNAs in human neocortex
development
To identify lncRNAs expressed during human neocor-
tical development, we microdissected radial sections of
the tissue at gestational weeks (GW) 13/14.5, 16, 21, and
23. For each time point, we obtained biological dupli-
cates and performed strand-specific RNA-seq of both
polyA selected RNA and total RNA that had been rRNA
depleted, generating over 200 million 100 bp paired-
end mapped reads from each tissue specimen (Fig. 1a,
Additional file 1: Table S1). After de novo transcrip-
tome assembly of the polyA selected RNA-seq reads,
previously annotated genes and short transcripts (<200 nt)
were filtered. Transcript models that did not pass an
optimized read coverage threshold in both biological
replicates were removed (“Methods,” Additional file 2:
Figure S1A). We then analyzed the protein coding poten-
tial of the remaining transcripts using three computational
tools: CPC, CPAT, and Pfam [22–24], and any tran-
scripts assigned a protein coding status by any of the
three methods were classified as transcripts of uncer-
tain coding potential (TUCP) [4] (Additional file 2:
Figure S1B). These newly annotated transcripts were
classified as intergenic, antisense, or intronic accord-
ing to previously proposed nomenclature standards
[25] and merged with the Ensembl build 75 transcrip-
tome, resulting in the Full transcriptome reference. A
Stringent transcriptome reference, in which novel
single-exon transcripts were removed, was also generated
(all deposited in GSE71315).
In our polyA selected reference transcriptomes, we
identified 11,642 lncRNAs (4124 multi-exonic) and 2571
TUCPs expressed in developing human neocortex (Fig. 1b;
Additional file 3: Table S2). The majority of lncRNAs were
intergenic, though strand-specific RNA-seq enabled iden-
tification of 3047 antisense lncRNAs (Fig. 1c). A total of
8180 lncRNAs were novel to Ensembl 75/GENCODE v19
(Additional file 4: Table S3). Total of 7492, 7892, and
2105 were novel to the annotations of Cabili et al. [4],
Hangauer et al. [7], and Mitranscriptome [6], respectively
(Additional file 2: Figure S1C). On average, lncRNAs were
detected at levels 13.6-fold lower than mRNAs
(Fig. 1d). Novel polyA transcripts annotated from hu-
man brain tissues had genomic characteristics and
conservation scores similar to previously annotated
lncRNAs (Additional file 5: Figure S2).
We next performed pairwise whole-transcriptome com-
parisons of all time points using DESeq2 [26] (FDR <0.01).
A total of 1088 mRNAs and 424 polyA lncRNAs/TUCPs
were differentially expressed across these time points
(Fig. 2a, Additional file 6: Table S4). Among differentially
expressed mRNAs, PAX6 and CENPA were elevated in
GW13-16, suggesting the increased presence of radial glia
stem cells [27]. Conversely, CUX2 and ADCY1 were ele-
vated in GW21-23, consistent with increased neurogenesis
at these time points [28]. Among differentially expressed
lncRNAs, MEG3 and DLX6-AS1 (a lncRNA antisense to
the interneuron transcription factor DLX6), increased
with developmental progression (Fig. 2b). Furthermore,
gene ontology (GO) analysis of lncRNA gene neighbors
suggested their function in neuronal differentiation
(Additional file 2: Figure S1F).
Some lncRNAs, such as MALAT1, have been described
to be non-polyadenylated [29]. To expand our catalogue
to include non-polyA lncRNAs, we performed de novo
transcriptome assembly with sequencing data from the
total RNA (rRNA depleted) from each tissue sample. Full
and Stringent lncRNA/TUCP references were generated
with the same pipeline used for polyA selected transcripts
(Fig. 1a). A total of 26,241 lncRNAs (4477 multi-exonic)
and 4606 TUCPs were annotated from the total RNA-seq
libraries (Additional file 2: Figure S1E). To identify tran-
scripts that are likely to be non-polyA, we analyzed genes
that were consistently >10-fold enriched in the total RNA
libraries versus the polyA libraries across all samples
(Fig. 2c, Additional file 7: Figure S3, and Additional file 8:
Table S5). mRNAs that encode specific histone subunits
are known to be non-polyA [30], and 52 out of the 58
mRNAs enriched in the total RNA-seq transcriptomes
were for histone subunits, including HIST1H2BK and
HIST2H2AB. By these methods, 85 lncRNAs were identi-
fied as non-polyA, with 65 being novel to Ensembl.
Among the previously annotated lncRNAs in this set,
known non-polyadenylated lncRNAs such as MALAT1,
Liu et al. Genome Biology  (2016) 17:67 Page 2 of 17
RMRP, and TERC, the RNA component of telomerase,
were identified [31]. Thus, our transcriptome references
allow broad profiling of lncRNAs during brain develop-
ment, regardless of genomic orientation or polyadenyla-
tion status.
Single-cell RNA-seq analysis of lncRNA expression
RNA-seq of whole tissues averages gene expression signa-
tures of many different cell types [20]. To study lncRNA
expression at single-cell resolution, we captured single cells
from radial sections of GW19.5, GW20.5, and GW23.5
neocortex (Fig. 3a). To mitigate the effects of technical
noise, we added equal amounts of ERCC Spike-In Control
RNA to each single-cell lysis reaction. PolyA libraries were
generated and a median of 1 million mapped read pairs
were obtained for each reaction (Additional file 1:
Table S1). We utilized our polyA Stringent transcrip-
tome reference to perform transcriptome-guided genomic
alignment and gene-level quantification of single-cell RNA-
seq reads (Methods). Cells in which we detected >1000
genes and >40 ERCC species were retained, resulting in
226 single cells for consideration. We also included 50
single-cell libraries from GW16 and GW21 that we previ-
ously sequenced [32] (Additional file 9: Figure S4A-C).
Although these libraries did not contain ERCC Spike-In
Controls, they expanded the developmental range of our
analyses.
To determine the sensitivity of our single-cell sequen-
cing, we calculated the detection rate of each ERCC species
(Additional file 9: Figure S4E). With the exception of
Fig. 1 Catalogue of lncRNAs in human neocortex development. a Schematic of neocortex tissue dissection, poly(A) and total RNA-seq library prep, and
computational pipeline for lncRNA annotation and quantification. b Numbers of expressed (left) and differentially expressed (right; DESeq2, FDR <0.01)
mRNAs, lncRNAs, and TUCPs during neocortex development in bulk tissues. Stringent references omit novel single exon transcripts. c Breakdown of
expressed (left) and differentially expressed (right) lncRNAs based on genomic orientation relative to mRNAs. d Maximum expression levels of transcripts
described in the Full and Stringent references derived from Poly(A) selection RNA-seq, across all samples. TPM, Transcripts per Million
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ERCC-00116, which is inefficiently sampled by polyA se-
lection [33], at more than eight copies, ERCCs were de-
tected in 99–100 % of cells. We then fit a linear regression
model relating normalized read counts (ncounts) to ERCC
molecules across all cells (Additional file 9: Figure S4F).
For our analyses, we included genes whose non-zero mean
levels were above 20.6 ncounts, corresponding to two
copies per cell. Furthermore, we omitted genes that were
detected in fewer than three cells unless there was evidence
of expression in our bulk RNA-seq data. Using these
methods, we detected 10,929 mRNAs and 1400 lncRNAs
expressed across the 276 cells (Additional file 10: Table S6).
Abundant lncRNA expression in subpopulations of
single cells
In tissue specimens, lncRNAs were detected at levels
13.6-fold lower than mRNAs on average, consistent
with previous reports [4, 5, 7] (Fig. 1d). To determine
Fig. 2 Differential expression of mRNAs and lncRNAs/TUCPs during neocortex development. a Heatmaps of differentially expressed mRNAs (left)
and lncRNAs/TUCPs (right) throughout eight samples of bulk neocortex tissues. b Strand-specific RNA-seq alignments at the DLX6-AS1 and MEG3
loci in GW16 and GW23 replicate one sample. Scale, number of aligned reads. c Comparison of mRNA (left) and lncRNA (right) expression levels
between poly(A) RNA-seq and total RNA-seq in GW16 sample 2. Red diagonals represent 10-fold enrichment in either total (upper) or polyA (lower)
fractions. Red triangles, histone subunits enriched >10-fold in total RNA. TPM, Transcripts per Million
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whether lncRNAs may be expressed at high levels by
subpopulations of cells, we analyzed the abundance of
lncRNAs by comparing the median expression of lncRNAs
to the median expression of mRNAs in each single cell
(lncRNA:mRNA median ratios). In single cells, the median
lncRNA:mRNA ratio was 0.85, with 32.2 % of cells ex-
ceeding 1.0 (Fig. 3b; Additional file 11: Figure S5A, F).
To investigate whether the lncRNAs analyzed in the
single cells exhibit lower expression in whole tissues,
we analyzed the same set of lncRNAs and mRNAs in
whole neocortical samples. In bulk tissue samples, the
lncRNA:mRNA ratios were significantly lower compared
to single-cell samples (median 0.31, p = 1.9 × 10–6, Mann–
Whitney U; Fig. 3b, Additional file 11: Figure S5B). Fur-
thermore, we merged the single cells in silico and found
that this “reconstituted” sample had a lncRNA:mRNA ratio
as low as the bulk tissues’ (ratio = 0.14, Fig. 3b; Additional
file 11: Figure S5C). Analyses of cultured non-neural cells
processed using the same single-cell isolation, library prep-
aration, and computational pipeline provided additional
evidence that the higher lncRNA:mRNA ratios observed in
single neocortex cells is not primarily driven by the
methods used (Additional file 12: Figure S6). Specifically,
the more homogenous K562 cell line exhibited single-cell
lncRNA:mRNA ratios (median 0.46) that were much lower
than those from neocortex cells (Additional file 12:
Figure S6A, D). Thus, lncRNAs that are detected at
low levels in whole tissues can be abundantly expressed in
individual cells.
To account for the observation that lncRNAs can be
abundant in individual cells but detected at low levels in
the whole tissues, we hypothesized that specific lncRNAs
Fig. 3 Single-cell transcriptomics of lncRNA expression. a Schematic of single-cell microfluidic capture and integration of transcriptome reference
generated from bulk tissue RNA-seq to conduct cell-type identification and lncRNA analysis. Previously captured cells from Pollen et al. [32] were
also included. b Distributions of median lncRNA expression to median mRNA expression ratios (lncRNA:mRNA) in bulk tissues, in silico merged single
cells, and single cells from the developing neocortex. c Proportion of neocortex cells that expressed each lncRNA (blue) and mRNA (red), separated by
maximum expression in single cells. d Same as in (c) but grouped by maximum expression quantile of the set of all transcripts (lncRNA and mRNA
combined). Green squares, housekeeping genes; black triangles, ERCC Spike-In Controls
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are expressed in subpopulations of cells. Housekeeping
genes were detected in the vast majority of the single
neocortex cells (median 91 %), as expected (Fig. 3c). In
contrast, across all quantiles of gene expression, lncRNAs
were detected in smaller proportions of cells than mRNAs
(p = 2.7 × 10–288, Mann–Whitney U; Fig. 3c, d). Consistent
with this observation, lncRNAs that were lowly detected
in bulk tissues were also expressed in fewer single cells
(Additional file 11: Figure S5D), indicating that in hetero-
geneous tissues lncRNAs are expressed in more discrete
populations of cells than mRNAs.
Cell type-specific expression of lncRNAs
To determine whether the discrete and abundant ex-
pression of lncRNAs could relate to their expression
in molecularly distinct cell types of the developing hu-
man brain, we performed hierarchical clustering of
single cells with genes that exhibited significant vari-
ability (Methods, Fig. 4a, Additional file 9: Figure S4D,
and Additional file 13: Figure S7). We identified seven
clusters, each comprising cells derived from at least
three different brains (Additional file 13: Figure S7).
To infer the identity of these cell clusters, we determined
the most specific mRNAs in each cluster (Methods,
Fig. 4b, Additional file 14: Table S7) and compared these
genes to known cell type-specific markers. With these
methods, we identified the cell clusters to be endothelial
cells (FLT1), radial glia (VIM, GFAP), dividing radial glia
(MKI67, TOP2A), intermediate progenitors (EOMES),
newborn neurons (SEMA3C, DCC), maturing excitatory
neurons (SATB2, ADCY1), and inhibitory interneurons
(DLX2, GAD1) [28, 34–36].
To identify cell type-specific lncRNAs, we ranked the
most specific lncRNAs of each cluster (Fig. 4c). Overall,
lncRNAs exhibited specificity scores comparable to those
of mRNAs, with lower abundance lncRNAs having slightly
greater specificity than abundance-matched mRNAs
(p = 0.01; Mann–Whitney U; Additional file 15: Figure
S8C). Notably, lncRNAs that were detected at lower
abundances in bulk tissues were more cell type-
specific in single cells than higher abundance lncRNAs
(p = 1.1 × 10–47, Mann–Whitney U; Additional file 15:
Figure S8D). Of the top 105 specific lncRNAs (15 in
each of seven clusters), 10 were not annotated in
Ensembl. DLX6-AS1, whose mean expression was
6123-fold higher in interneurons than in all other cell
types, exhibited the highest cell type-specific enrich-
ment of any gene (Fig. 4c). Its mouse ortholog Evf2 has
been shown to function in interneurons [3, 37]. While
MEG3 and SOX2-OT have been shown as brain- and
even neuron-specific [34], our clustering revealed these
lncRNAs to be more specific to interneurons than to
newborn or maturing excitatory neurons (Fig. 4c).
Gene co-expression analyses have previously been used
to infer biological functions for novel lncRNAs [5, 38]. We
therefore constructed co-expression networks between the
top specific lncRNAs and all mRNAs expressed in the sin-
gle cells (Additional file 16: Figure S9A). Isolating the top
10 % most correlated or anticorrelated mRNAs to these
lncRNAs revealed gene clusters with cell type-specific
function, such as “angiogenesis” for the endothelial
lncRNAs and “GABA synthesis, release, reuptake and
degradation” for the interneuron lncRNAs (Additional
file 16: Figure S9B).
To validate our cell type-specific lncRNA expression
patterns, we performed in situ hybridizations for three
lncRNAs: LOC646329 (radial glia), LINC00599 (ma-
turing neuron), and DLX6-AS1 (interneuron) (Fig. 5a).
LOC646329 was enriched in the ventricular zone (VZ),
where most radial glia reside. LINC00599 was enriched in
the cortical plate (CP), which harbors maturing neurons.
DLX6-AS1 was enriched in the subpial granular layer and
also exhibited a gradient of punctate expression spanning
from the VZ to the intermediate zone (IZ), consistent with
the migration patterns of cortical interneurons [39, 40].
Imaging of the radial glial marker PAX6, the neuron
marker RTN1, the maturing neuron marker ADRA2A,
and the control marker NNAT, which is expressed broadly
across progenitor and differentiated cells [32], further
validated the regional expression patterns of the cell type-
specific lncRNAs (Fig. 5b, Additional file 17: Figure S10).
To ask whether cell type-specific expression contributes
to genes being detected at low levels in tissues, we ana-
lyzed the expression levels of the top 105 cell-type specific
mRNAs and lncRNAs. As expected, in bulk tissues, cell
type-specific mRNAs were detected at lower levels as
compared to housekeeping genes (Fig. 6b). Cell type-
specific lncRNAs were detected at even lower abundances
than housekeeping genes (0.069-fold). In contrast, in
single cells, these lncRNAs were detected at levels close
to those of housekeeping genes (0.436-fold, Fig. 6a,
Additional file 15: Figure S8A, B). Thus, these cell type-
specific lncRNAs appeared 6.31 times less abundant in
bulk tissues as compared to their expression in single
cells.
We then reasoned that the tissue level expression of a
given gene could be modeled as a weighted average of
cell type-specific expression, where the weights are pro-
portional to the relative abundance of each cell type. We
used multiple linear regression to estimate the expected
fraction of each cell type, using the mean expression in
each cell type as predictor variables and bulk expression
as the response. For consistency, only single cells derived
from all cortical layers between GW19.5 and 23.5 were
considered, and only bulk tissues from GW21–23 were
used. Remarkably, the expected fractions of cell types
showed strong agreement with the observed cell types
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identified in this study (Fig. 6c). This was true for
models using lncRNAs only (r = 0.81) and mRNAs only
(r = 0.87), showing that the degree of decreased expres-
sion in bulk tissues can be explained largely by the
relative abundances of cell types. Nonetheless, the dis-
creteness of lncRNA expression (Fig. 3d), and the rela-
tively lower explanatory power of the lncRNA linear
model (R2 = 0.336; mRNA R2 = 0.422) suggest that
lncRNAs exhibit additional expression variation even
within cell types.
Radial glia-enriched lncRNA LOC646329 regulates cell
proliferation
LOC646329 was among the most radial glia-enriched
lncRNAs, and it was also detected at very low levels in
bulk tissues (Transcripts per Million (TPM) <0.5, Figs. 4c
and 7a). Radial glia – the neural stem cell population of
the developing brain – share biological and transcriptional
characteristics with glioblastoma multiforme (GBM), a
malignant glial tumor (Fig. 7b) [41]. LOC646329 is
expressed in human GBM, including the U87 GBM cell
Fig. 4 Cell type-specific expression of lncRNAs. a Identifying cell types using unsupervised clustering. Left – Principal component analysis (PCA) of single
cells colored by developmental stage of source tissues. Middle – Complete linkage hierarchical clustering of single cells using genes exhibiting variance
greater than expected than from technical noise. Right – PCA of single cells colored by cell types inferred from protein coding genes specific to each
cluster. Axes labels indicate percent variation explained by each PC. b Heatmaps of cell type enrichment scores for the 15 most specific mRNAs and (c)
lncRNAs in each cluster. GW21p3, primary cells derived from GW21 brain that were cultured in differentiation media for 3 days
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line (Fig. 7a, b). To investigate the biological function
of LOC646329, we performed CRISPRi knockdown of
the lncRNA in U87 cells. U87 cells stably expressing
dCas9-KRAB were infected with one of two lentiviruses
harboring distinct sgRNAs targeting the transcription
start site of LOC646329 (Fig. 7a). After confirming
knockdown of LOC646329 by qPCR, we performed intern-
ally controlled growth assays by measuring the percentage
of cells infected with sgRNA-expressing lentivirus over
time (Fig. 7c, d). Knockdown of LOC646329 with either
sgRNA reduced the propagation of U87 cells, indicating an
important role for this lncRNA in cell proliferation.
Discussion
LncRNAs are remarkably tissue specific [1, 4, 5] and the
mammalian brain expresses a tremendous diversity and
number of this class of non-coding transcripts [4, 9].
Furthermore, some neural lncRNAs are primate and/or
human specific, suggesting that lncRNAs play a role in
the evolutionary expansion of the human neocortex
[42, 43]. To lay groundwork for the study of lncRNAs
in human brain development and disease, we generated
a reference catalogue of lncRNAs expressed at different
stages of human neocortex development.
Our human neocortex lncRNA reference catalogue
greatly improves upon previous annotations of human
neural lncRNAs in several ways [15, 43]. First, we studied
several developmental stages (eight samples spanning
GW13 to GW23). Second, we analyzed both polyA se-
lected and total RNA from each of the tissue specimens,
which enabled the identification of novel lncRNAs that
are potentially non-polyadenylated. Third, all of our
cDNA libraries retained strand-of-origin information,
allowing more accurate annotation and quantification
of antisense transcripts, several of which have been
shown to have important functions [17–19]. Finally, the
inclusion of biological replicate samples at matched (or
near matched) developmental stages also allowed us to
identify lncRNAs that were differentially expressed over
time. We anticipate that this reference will facilitate future
Fig. 5 In situ hybridization of cell type-specific lncRNAs and mRNAs in developing neocortex. a In situ hybridizations and corresponding cell type
enrichment values for radial glia-specific lncRNA LOC646329 (left), maturing neuron-specific lncRNA LINC00599 (middle), and interneuron-specific
lncRNA DLX6-AS1 (right). b In situ hybridizations and corresponding cell type enrichment values for radial glia-specific mRNA PAX6 (left), neuron
mRNA marker RTN1 (middle), and progenitor and differentiated cell-expressed mRNA NNAT (right). Scale bars, 250 μm. CP, cortical plate. IZ, intermediate
zone. SVZ, subventricular zone. VZ, ventricular zone
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studies focusing on the roles of lncRNAs in cortical de-
velopment and evolution, including cell type-specific
roles of individual lncRNAs.
Our single-cell transcriptome analyses indicate that
lncRNAs can be highly expressed in individual cells of
the developing neocortex. In cultured cells, studies using
single molecule fluorescence in situ hybridization (FISH)
demonstrate relatively uniform expression of 61 different
lncRNAs across all cells, and that cells expressing high
levels of specific lncRNAs are uncommon [21]. Consistent
with these observations in cell lines, we found that lncRNA
abundance is uniformly low to moderate in single cells of
the relatively homogenous K562 leukemia line (Additional
file 12: Figure S6A, D). In contrast, single cells from devel-
oping human neocortex exhibited a wide range of lncRNA
abundances, with some lncRNAs such as SOX2-OT and
DLX6-AS1 reaching levels higher than those of housekeep-
ing genes (Fig. 6a, Additional file 15: Figure S8B). Given
that the cultured K562 and human neocortex cells were all
processed using the same Fluidigm C1 platform and proc-
essed with the same computational pipeline, the discrete
and abundant expression of lncRNAs in neocortical cells
likely relates to differences in their cellular identity.
Consistent with this hypothesis of cellular identity
explaining lncRNA expression, our results indicate pref-
erential “dilution” of lncRNAs in bulk samples (Fig. 6a),
suggesting that cell type-specific expression of lncRNAs
contributes to the apparent low expression of lncRNAs
in heterogenous tissues. Furthermore, we were able to
predict the relative abundances of the cell types identi-
fied in this study by regressing bulk expression onto cell
type-specific expression (Fig. 6c). However, two caveats
are that we have not captured all the cell types in the de-
veloping human cortex, and we have not ruled out the
possibility that the processing of single cells may enrich
for certain cell types. A much larger scale study, such as
those performed on the adult mouse brain [44] and retina
[45], would be required to better understand relative
abundances of cell types in the developing human brain.
Quantitative measurements in single-cell RNA-seq
have been refined by the use of unique molecular identi-
fiers (UMIs) that deconvolute non-uniform amplification
Fig. 6 Cell type-specific lncRNAs appear to be lowly expressed in bulk tissues. a Comparison of single-cell and bulk tissue maximum expression
levels of 105 cell type-specific lncRNAs and (b) 105 cell type-specific mRNAs. Green, housekeeping genes; blue, cell type-specific lncRNAs; red, cell
type-specific mRNAs. Projected density plots summarize expression levels of scatterplots along the single-cell (horizontal) and bulk tissue (vertical)
axes. Fold changes noted alongside the projected density plots represent the ratio of the median expression of cell type-specific lncRNAs or
mRNAs to the median expression of housekeeping genes in single cell or whole tissue RNA-seq. c Comparison of expected cell type fractions as
predicted by linear regression (x axis) and observed cell type fractions (y axis). TPM, Transcripts per million; Endo, endothelial; rg, radial glia; drg,
dividing radial glia; ipc, intermediate progenitor cell; nn, newborn neurons; mn, maturing neurons; inter, interneurons
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of cDNA [44–47]. However, these methods are not yet
compatible with full-length transcript coverage, which is
advantageous for the study of lncRNAs. We retained full-
length transcript coverage using the SMARTer protocol
and instead used ERCC Spike-In Control RNA to control
for technical noise. Our use of these synthetic RNA spikes
to determine an expression threshold and to identify vari-
able genes greatly diminished technical noise as the pri-
mary driver of lncRNA abundance. However, the use of
spike-ins set a lower bound of detection and many truly
low abundance lncRNAs likely fell below this threshold.
Nonetheless, the same threshold was also used for
mRNAs, and our internal comparisons of lncRNAs to
mRNAs in the same cell also controls for technical noise,
especially since lncRNAs are not necessarily less stable
than mRNAs [48]. Therefore, our observation of discrete
and abundant expression of lncRNAs in individual cells is
not primarily driven by technical noise.
Several lncRNAs have previously been described as
brain specific [4, 12, 43]. In this study, we found that
these as well as novel lncRNAs can be further attributed
to distinct cell types within the neocortex. For instance,
MEG3 is highly expressed in the brain [4, 49] and we
found this lncRNA to be especially enriched in interneu-
rons, with moderate expression in maturing excitatory
neurons (Fig. 4c). We also identified cell type-specific
and cortical layer-specific expression of lncRNAs such
as LINC00599 and LOC646329 (Fig. 5), which have not
been studied at this resolution in the human brain. In
addition, our study of cell type-specific transcripts re-
vealed a role for LOC646329 in regulating cell prolifera-
tion. Determining whether LOC646329 acts as a host to
Fig. 7 CRISPRi knockdown of radial glia-enriched lncRNA LOC646329 inhibits proliferation. a RNA-seq alignments at the LOC646329 locus.
GW16(+)/(–) replicate one and U87 alignments are number of reads. Radial glia and maturing neurons are merged alignments normalized by
number of cells within each cell cluster. sgRNAs targeting the TSS of LOC646329 are indicated. b Expression of radial glia and neuron mRNAs
and lncRNAs in U87 glioblastoma cells. c qPCR of LOC646329 following 4 days of CRISPRi knockdown using two sgRNAs targeting the TSS of
LOC646329 relative to non-targeting control sgRNA. Biological triplicates (black circles) show 79.0 % repression with sgLOC646329-1 (p = 0.0014; Welch’s
t-test) and 62.6 % repression in sgLOC646329-2 (p = 0.0035; Welch’s t-test). Red lines, mean. d Relative growth assays of U87 cells following
sgRNA infection. sgRNA+ fraction was calculated relative to 5 days post sgRNA infection and normalized to the sgCtrl+ fraction at each time
point. Biological triplicates show 28.1 % depletion at 20 days with sgLOC646329-1 (p = 0.0073; Welch’s t-test) and 33.5 % depletion with
sgLOC646329-2 (p = 0.00048; Welch’s t-test). Error bars, standard deviation of triplicate cultures
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the microRNAs MIR29A/B1 (Fig. 7a) or through a dis-
tinct and separable role [50] will require further investi-
gation. Nonetheless, this result illustrates that lncRNAs
that appear to be lowly expressed in tissues can have im-
portant functions and motivates the study of lncRNAs at
the single-cell level.
Conclusions
Whole transcriptome analysis of single cells, in combin-
ation with deep RNA-seq of tissues, allowed us to identify
abundant cell type-specific lncRNAs in the developing
neocortex. Importantly, many lncRNAs that appear lowly
expressed at the population level are abundant in discrete
cell types. Analysis of these lncRNAs in the brain both
reveals useful markers of cell types during lineage progres-
sion from precursor to differentiated cell types and en-
ables the discovery of novel cellular functions of lncRNAs.
As such, lncRNAs that are lowly expressed in a population
may still regulate essential functions and should not be
discounted solely based on apparent abundance. These
data and workflow should facilitate future studies aimed at




De-identified human prenatal brain tissue samples were
collected from elective pregnancy termination specimens,
usually within 2 h of the procedure. Gestational age
was determined by measuring foot length and tissues
were transported on ice in Leibowitz-15 medium for
immediate tissue processing and RNA extraction.
Ethics
Research protocols were approved by the Human Gamete,
Embryo, and Stem Cell Research (GESCR) Committee
(Institutional Review Board) at University of California,
San Francisco (10-03379). Donated specimens were
examined only from patients who had previously
given informed consent and in strict observance of
state and institutional legal and ethical requirements. All
experimental methods comply with the Declaration of
Helsinki.
Bulk tissue RNA-seq library preparation
Fresh neocortex tissues were dissected along the radial
axis, and 50–100 mg sections spanning the ventricular
zone to the marginal zone of the neocortex were
harvested in TRIzol. Mixtures were homogenized by
triturating 10 times through a 21G needle. Ethanol ex-
tracted RNA was loaded onto RNeasy columns (QIAGEN)
and on-column DNase treatment was performed as previ-
ously described [5]. Purified RNA samples produced RIN
scores between 8.6 and 9.5, measured by 2100 Bioanalyzer
(Agilent). RNA-seq libraries were generated using both
TruSeq Stranded mRNA and TruSeq Stranded Total RNA
with Ribo-Zero Gold kits (Illumina) according to the manu-
facturer’s protocols. cDNA validation and normalization
were performed using RT-PCR and Quant-iT PicoGreen
(Invitrogen). Cluster generation and high-throughput se-
quencing were performed on a HiSeq 2500 (Illumina),
using the paired-end 100 bp protocol.
Single-cell capture and RNA-seq library preparation
Tissues were microdissected by embedding in 3.5 % low
melt agarose (Fisher) and sectioned along the radial axis,
perpendicular to the ventricles, using a Leica VT1200S
vibratome in artificial cerebrospinal fluid (ACSF) media
containing 125 mM NaCl, 2.5 mM KCl, 1 mM MgCl2,
1 mM CaCl2, and 1.25 mM NaH2PO4. Cortex dissections
were added to papain (Worthington Biochem. Corp) and
2000 units/mL of DNase I freshly diluted in EBSS and in-
cubated at 37 ° C for 30 min and centrifuged for 5 min at
300 g. Supernatants were removed and dissociated cells
were resuspended in 0.5 mL of sterile DPBS containing
3 % FBS (Sigma) and 1000 units of DNAse I. Suspensions
were further dissociated by pipetting up and down 10
times and then passing through a 40 μm strainer cap (BD
Falcon) to yield single-cell suspensions. Single-cell dissocia-
tions were performed on samples separate from those used
for bulk tissue RNA-seq.
Single-cell capture was performed using the Fluidigm C1
Single-Cell Auto Prep Integrated Fluidic Circuit (IFC) and
SMARTer Ultra Low RNA Kit as previously described
[32]. We minimized the capture of cell doublets by only
using small (5–10 μm) 96-plex IFCs, which in combination
with neural cells were demonstrated to have the lowest in-
stance of doublets (median 6 %, SD 4 %) [51]. ERCC Spike-
In Controls (Ambion) were added to each single-cell lysis
reaction at a final dilution of 1:20,000, in order to capture a
wide range of molecule count per reaction. cDNA was
quantified using High Sensitivity DNA Kits (Agilent) and
diluted to 0.15–0.30 ng/μL in C1 Harvest Reagent. Dual
indexing and amplification were performed using the
Nextera XT DNA Sample Preparation Kit (illumina)
with the following modifications: reactions were performed
at one-quarter of the recommended volume, tagmentation
proceeded for 10 min, and the PCR extension time was
60 s. Amplified cDNA was size selected twice using
0.9X volume of Agencourt AMPure XP beads (Beckman
Coulter). Final cDNA libraries were quantified using High
Sensitivity DNA Kits (Agilent) and sequenced on a HiSeq
2500 (Illumina), using the paired-end 100 bp protocol.
LncRNA identification and quantification pipeline – bulk
whole tissues alignment and de novo transcript assembly
Quality control of RNA-seq reads was performed using
FastQC. No read trimming was performed on reads from
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bulk tissues, since all samples exhibited 25%ile quality
scores above Q30 at all 100 bp positions. Strand-specific
reads were aligned to the human reference genome,
Ensembl GRCh37/hg19 release 75, using TopHat v2.0.10
with the flags (–library-type fr-firststrand –microexon-
search). Each sample generated between 105 and 148 mil-
lion mapped read pairs from rRNA depleted total RNA-
seq, and between 60 and 105 million mapped read pairs
from polyA selection RNA-seq (Additional file 1: Table
S1). De novo transcriptome assembly was performed
separately on rRNA depletion total RNA-seq align-
ments, and on polyA selection RNA-seq alignments, using
Cufflinks v2.2.1 with the flags (-M ensembl_75_mtR-
NA_rRNA.gtf -b genome.fa -u –library-type fr-firststrand –
max-multiread-fraction 0.25 –3-overhang-tolerance 2000)
to mask potential rRNA and mtRNA reads, enable bias cor-
rection and multi-map correction, and also to reduce the
identification of polymerase run-on fragments as novel
transcripts [52]. Transcriptome assemblies at all develop-
mental stages and replicates were merged, separately for
rRNA depletion total RNA-seq and polyA selection RNA-
seq, with the Ensembl 75/GENCODE 19 reference tran-
scriptome, using Cuffmerge. To identify transcripts novel
as compared with Ensembl, we utilized Cuffcompare class
codes and extracted those assembled transcripts classified
as: i – novel intronic, u – novel intergenic, x – novel anti-
sense. All novel transcripts under 200 nt in length were re-
moved. Of the remaining transcripts, we determined
minimal read coverage thresholds based on whether Cuf-
flinks classified previously annotated transcripts as having
“full_read_support.” By analyzing the true positive rate
versus false positive rate of classifying known genes as
obtaining “full_read_support” at various coverage thresh-
olds, we determined the minimum coverage to be 1.4 for
polyA and 1.67 for total RNA-seq (at FDR = 0.05).
Starting with just the polyA RNA-seq data, transcripts
with read coverage above 1.4 in both biological replicates
of at least one developmental stage were included in the
reference and considered to be expressed in the neocor-
tex. Due to limited availability of early fetal tissue, the
GW14.5 sample was treated as the biological duplicate
of the GW13 sample. Novel transcripts that were pre-
dicted to have protein coding capability by one or more
of the following methods were classified as transcripts of
uncertain coding potential (TUCP): CPAT [23], thresh-
old = 0.364; CPC [22], threshold = 0; Pfam [24]. For com-
paring to the Pfam database, the longest potential open
reading frame (ORF) of each novel transcript was ob-
tained and any putative ORF that had a significant
match for a protein domain annotated in Pfam A or
Pfam B resulted in the parent transcript being classified
as a TUCP. All remaining novel lncRNAs and TUCPs
were then named according to recently proposed no-
menclature standards [25], for instance LINC-[nearest
mRNA] for intergenic lncRNAs and [nearest mRNA]-AS
for antisense lncRNAs, and were then merged to the
Ensembl 75 reference transcriptome, resulting in the
polyA Full reference transcriptome. The polyA Stringent
reference transcriptome was produced by removing all
novel single-exon lncRNAs and TUCPs. Known lncRNAs
from Ensembl were obtained by identifying transcripts
with one of the following biotype classifications: “3prime_
overlapping_ncrna,” “antisense,” “lincRNA,” “processed_
transcript,” “sense_intronic,” and “sense_overlapping.”
The same pipeline, with the coverage threshold of 1.67,
was performed for reads derived from the total RNA-seq.
LncRNA quantification
Gene-level fragment counts for each polyA and total
RNA sample were quantified using featureCounts v1.4.6
[53], using the flags: -p -s 2 -B -C -t exon -g gene_id.
Count tables were normalized to Transcripts per Million
[54] for internal comparisons and visualizations of bulk
RNA-seq. To identify differentially expressed genes, we
used DESeq2 [26] on gene-level fragment counts derived
from the polyA samples and polyA Full reference tran-
scriptome. Pairwise negative binomial significance tests
were performed between developmental stages using
biological duplicates and the union of genes that were
significant at FDR <0.01 were classified as differentially
expressed. Gene ontology (GO) analysis was performed
using the DAVID web server [55]. To identify lncRNAs
enriched in total RNA versus polyA RNA, we first iden-
tified all transcript annotations in the total Full reference
that did not overlap with transcripts in the polyA Full
reference. We then merged these transcripts with the
polyA Full reference. We quantified gene-level fragment
counts annotated in this augmented reference using all
samples (both polyA RNA and total RNA), as described
above. For each of the eight tissue samples, we then
compared the TPM for each gene as observed from the
polyA and total RNA-seq. mRNAs and lncRNAs that
were consistently >10-fold enriched in one or the other
fraction across all eight samples were then considered
enriched in total RNA or enriched in polyA RNA.
Quality control and analysis of single-cell RNA-seq
Paired end 100 reads from single-cell cDNA libraries
were quality trimmed using Trim Galore with the
flags: -q 20 –nextera –length 20. Trimmed reads were
aligned to the human reference genome, Ensembl GR
Ch37/hg19 release 75, augmented with the 92 ERCC
Spike-In Control sequences, using TopHat v2.0.10
with the flags: –transcriptome-index = polya_stringen-
t_reference.gtf –prefilter-multihits. The polyA Strin-
gent reference transcriptome, derived from bulk tissue
RNA-seq as described above, was used as a transcriptome
reference. A median of 1 million 100 bp paired-end reads
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were successfully aligned per cell. Gene-level fragment
counts were quantified using featureCounts v1.4.6 with
the flags: -p -B -C -t exon -g gene_id. Since the SMARTer
cDNA prep does not retain strand-of-origin information,
we did not count reads that overlapped multiple features,
even if they were annotated on opposite strands. Outlier
identification was performed by calculating the number of
genes and ERCC species detected in each cell (defined as
the number of genes with >1 count). The distribution of
genes and ERCCs detected decayed rapidly below 1000
genes and 40 spikes, with the remaining few samples
centered at 0 genes and 0 spikes (Additional file 9:
Figure S4A, B). Therefore, we excluded from analyses
cells in which we detected fewer than 1000 genes and
40 ERCC spikes. The >40 ERCC requirement was not
used for previously sequenced single cells from Pollen
et al. [32], as these cells from GW16 and GW21 brains
did not contain ERCC Spike-In Controls.
To determine the most accurate expression metric to
use for our single-cell transcriptome analyses, we corre-
lated absolute ERCC spike abundances in each cell with
their expression readout using four different metrics
(Additional file 9: Figure S4J). Count-based metrics,
which were counts and CPM (Counts per Million mapped
reads), outperformed length-normalized metrics, which
were FPKM (Fragments per Kilobase per Million mapped
reads) and TPM (Transcripts per Million). Therefore, we
used counts and normalized each single-cell library by
transcriptome size factors according to DESeq [26].
Separate size factors were calculated and used for genes
and ERCCs.
Detection rate analysis was performed by calculating
for each gene and ERCC spike the number of cells out
of the 276 neocortex cells that exhibited >1 normalized
counts for that gene. We determined that the sensitivity
of detection was 74 % for a ERCC species present at two
copies per cell. At more than eight copies per cell,
ERCCs were detected in 99–100 % of cells (Additional
file 9: Figure S4E). The exception was ERCC-00116,
which is known to be inefficiently sampled by polyA se-
lection [33]. To find a reliable count threshold for fur-
ther analyses, we then fit a linear regression model
relating normalized read counts (ncounts) to ERCC
molecules across all cells (Additional file 9: Figure S4F).
We then included genes whose non-zero mean levels
across all cells were above 20.6 ncounts, corresponding
to two copies per cell. Furthermore, we omitted genes
that were detected in fewer than three single cells unless
they were considered to be expressed by the whole-
tissue RNA-seq experiments. For single-cell comparisons
of gene expression levels of lncRNAs to mRNAs, only
genes that were expressed above two normalized counts
in each cell were considered. The median normalized
counts for lncRNAs was then compared to the median
normalized counts for mRNAs in single cells. In silico
merged cells in Fig. 3b and Additional file 11: Figure
S5C were generated by taking the sum of gene read
counts across all single cells that passed QC.
Clustering and cell type identification of single cells
To identify genes for unsupervised clustering, we modeled
technical noise using ERCC Spike-In Control RNA and
identified genes with significantly greater expression vari-
ation than expected from noise according to Brennecke
et al. [56]. Briefly, we fit a gamma family generalized linear
model to the coefficient of variation squared of ERCCs as a
function of mean normalized counts. We then determine
the expected variance model for genes that exhibit greater
than 50 % biological coefficient of variation at FDR <0.01
(Benjamini–Hochberg adjusted p value from Chi-square
distribution). These 5243 remaining genes were then used
for principal component analysis (PCA). PCA was per-
formed using log2 size factor-normalized counts with a
pseudocount of 1 and visualized in R. We then ranked all
genes (mRNAs and lncRNAs) based on their highest abso-
lute values of gene loading scores across the first four prin-
cipal components in PCA. We then performed complete
linkage hierarchical clustering of single-cell expression
(log2(Normalized Counts + 1)) using 1-(Pearson correl-
ation coefficients) as the distance metric, using the top
500 genes ranked by PCA loading scores (Additional
file 13: Figure S7). Cluster dendrograms were cut static-
ally between r = 0.8 and r = 0.9, and cell types were in-
ferred by comparing mRNAs specific to each cluster to
known markers.
Cell type-specificity analysis
Cell type-specificity for each gene was calculated as the
odds ratio of a cell expressing a given gene, above a
given threshold, within a cluster compared to outside a
cluster. Specifically, if pij is the fraction of cells express-
ing gene i above threshold in cluster j, and qij is the frac-
tion of cells expressing gene i above threshold that are
not in cluster j, then we measure cell type specific ex-
pression odds by: θij ¼ log pij 1−qijð Þqij 1−pijð Þ. To generate the set of
mRNAs and lncRNAs specific to each cell type, we first
assigned each gene to a cell type by determining which
cell type yielded the maximum log odds specificity score
for that gene. We used each gene’s own 75%ile for ex-
pression thresholds. Then we calculated expression
enrichment scores for each gene in each cell type by:
eij = uij/vij, where uij is the mean expression level of
gene i within cluster j, and vij is the mean expression
level of gene i outside of cluster j. Genes were ranked
within their cell type cluster assignments using ex-
pression enrichment scores and the top 15 mRNAs
and lncRNAs in each cell type were obtained.
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Linear regression model
We reasoned that the relationship between bulk tissue
RNA-seq expression and single-cell RNA-seq expression
could be approximated using multiple linear regression
in the form:
Y ¼ β0 þ β1X1 þ β2X2 þ…þ βnXn
where Y is bulk expression, n is the number of cell types
identified in the study, β0 is a constant that normalizes
global differences between single-cell and bulk RNA-seq,
[β1 … βn] is the vector of slope coefficients that are pro-
portional to the relative fraction of each cell type within
the bulk tissue, and X is the vector of mean expression
of each cell type as measured by single-cell RNA-seq.
Expression values were represented as log2 transformed,
size factor-normalized counts, with a pseudocount of 1.
To improve matching between bulk tissues and single
cells, we used the mean expression of GW21 and GW23
bulk cortex samples (n = 4) as the bulk expression level,
and we used single cells derived from all cortical layers
between GW19.5 and 23.5 (n = 226) and calculated the
mean expression for each cell type, as was determined
by hierarchical clustering in Fig. 4. Only genes that
passed the single-cell expression threshold (described
above), and were detected above 5 counts in bulk tis-
sues, were included. The data were then fit using the lm
function in R, and the resulting slope coefficients were
normalized such that ∑i = 1
n βi = 1. These normalized coef-
ficients, which represent the expected fractions of cell
types, were then compared to the observed relative frac-
tions of cell types, according to the cluster sizes in Fig. 4
(but only counting the 226 included cells).
Gene co-expression analysis
A correlation matrix was assembled by calculating all
pairwise Pearson correlation coefficients between the
105 cell type-specific lncRNAs and all expressed mRNAs
across single cells. Expression values were represented as
log2 transformed, size factor-normalized counts, with a
pseudocount of 1. mRNAs whose maximum, absolute
value correlation coefficients were in the top 10%ile were
kept. The resulting sub-matrix was clustered using Eu-
clidean distance and complete linkage, and gene clusters
were analyzed for gene ontology terms using Enrichr
[57]. Clusters with significant gene ontology terms are
represented in Additional file 16: Figure S9.
In situ hybridization
Probes for in situ hybridization were synthesized
(Genscript) or cloned from GW16 human fetal neocortex
cDNA, which were reverse-transcribed using SuperscriptII
(Invitrogen) with random hexamer primers. Probe se-
quences were subcloned into pGEM T-Easy vector
(Promega). T7 or SP6 RNA polymerase (Roche) was
then used for in vitro transcription of the probes, in the
presence of DIG-RNA Labeling Mix (Roche). In situ
hybridization was performed blinded to the sense/anti-
sense status for each probe and sense control probes gave
no signal (data not shown). The in situ hybridization
protocol has been described before [58]. Images were
collected with a Leica DMI 4000B microscope using a
Leica DFC295 camera.
Immunohistochemistry
Immunohistochemistry was performed as described in
Pollen et al. [32]. Briefly, tissue samples were fixed in
4 % paraformaldehyde, cryoprotected in 30 % sucrose,
and embedded in a 1:1 mixture of 30 % sucrose and op-
timal cutting temperature (Thermo Scientific). Cryosec-
tions of 20 μm were collected using a Leica CM3050S
cryostat. Primary antibody: ADRA2A (1:100, Thermo
Scientific, PA1-048). Heat-induced antigen retrieval was
performed in 10 mM sodium citrate buffer, pH 6. Binding
was revealed using Alexa Fluor™ 488 fluorophore-
conjugated secondary antibody (Life Technologies). Im-
ages were collected with a Leica TCS SP5 X Confocal
microscope.
CRISPRi knockdown of lncRNAs
CRISPRi mediated repression of lncRNA transcription
was performed as described previously [59]. First, we
created a stable polyclonal cell line expressing dCas9-
KRAB by transducing U87 glioblastoma cells with
dCas9-KRAB-BFP lentivirus and sorting for the top
30 % of BFP expressing cells. sgRNAs were designed as
previously described [59]. sgRNA protospacer sequences
were: sgLOC646329-1, GCTTAGGAAATCACCAGCTCC;
sgLOC646329-2, GGTCTGCCGTGACAGTTCAGT; sgC
trl, GAACGACTAGTTAGGCGTGTA. We then cloned
the sgRNA sequences into puromycin-resistant lentiviral
vectors and infected dCas9-KRAB U87 cells with the result-
ing lentivirus particles. To assess lncRNA knockdown, we
treated cells with 1 μg/mL puromycin for 4 days following
sgRNA infection and performed RT-qPCR as previously de-
scribed [59]. RT-qPCR primers were: LOC646329 Forward,
CTTGGGGATCCTCTGTACGC; LOC646329 Reverse,
CTTCGGTATCCTGATGTAGGTGT.
Internally controlled, relative growth assays were per-
formed separately. Triplicates cultures of dCas9-KRAB
U87 cells were transduced at 40–50 % infection rate
with lentiviruses harboring sgRNAs. The proportion of
cells that were BFPhi ,indicating sgRNA expression, in
each population was measured at every passage (every
other day) by an LSR II flow cytometer (BD). These pro-
portions were internally normalized to values at 5 days,
when all infected cells reached full sgRNA expression,
and then compared to cells infected with non-targeting
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control sgRNAs, which demonstrated stable expression
of the sgRNA containing vector.
Availability of supporting data
All sequencing data, bulk RNA-seq alignment signal, ref-
erence transcriptome GTF files, and expression tables are
deposited in GSE71315. Glioblastoma cell line U87 RNA-
seq data were obtained from GSE29738. Single-cell RNA-
seq libraries from the 50 GW16 and GW21 samples and
the 46 K562 cells were obtained from SRP041736.
Additional files
Additional file 1: Table S1. Related to Figs. 1 and 3. Sample and
sequencing statistics. Developmental stages, number of reads sequenced
and aligned for each bulk RNA-seq and single-cell RNA-seq sample (separate
tabs in xls file). Single-cell RNA-seq statistics also include number of unique
genes and ERCC Spike-In Control species detected, and how many reads
were assigned to either. (XLS 44 kb)
Additional file 2: Figure S1. Computational pipeline of lncRNA
identification. A ROC analysis of coverage thresholds required to fully
annotate known transcripts in poly(A) and total RNA-seq data. Coverage
thresholds were selected for which false positive rates were 0.05,
corresponding to the optimal balance of false positive and true positive
rates. B Venn diagrams of novel transcripts classified as protein coding
by CPC, CPAT, and Pfam search. The union of the transcripts were
annotated TUCPs. C Number of novel poly(A) lncRNAs expressed in the
Full (red) and Stringent (blue) references compared to Cabili et al. 2011,
Ensembl 75/GENCODE 19, Hangauer et al. [7], and Iyer et al. [6]
(MiTranscriptome). D Maximum expression levels of transcripts described in
the Full (white) and Stringent (gray) references derived total RNA-seq across
all samples. TPM, Transcripts per Million. E Numbers of expressed mRNAs,
lncRNAs, and TUCPs during neocortex development in bulk tissues, according
to total RNA-seq libraries. F Top gene ontology terms for differentially
expressed mRNAs (left) and mRNA neighbors of lncRNAs/TUCPs (right).
(PDF 165 kb)
Additional file 3: Table S2. Related to Fig. 1. Expression table of all
bulk tissue samples and genes (including known and novel lncRNAs)
according to the polyA Full transcriptome reference. Expression values
are in TPM (Transcripts per Million). (XLS 9972 kb)
Additional file 4: Table S3. Related to Figure S1. Table of novel lncRNAs
not annotated in Ensembl release 75. Gene names and coordinates are in
BED format. These lncRNAs were the set of novel lncRNAs annotated in the
polyA full reference, which includes both multi-exon and single exon
lncRNAs. (XLS 1429 kb)
Additional file 5: Figure S2. Genomic characteristics of lncRNAs
expressed in human neocortex development. A Cumulative distributions
transcript length of mRNAs, Ensembl lncRNAs, and lncRNAs/TUCPs in the
Full and Stringent references not annotated in Ensembl (novel). B
Cumulative distributions of distances between mRNAs or lncRNAs/TUCPs
to their closest mRNA neighbors. Novel lncRNAs/TUCPs were farther from
mRNAs than mRNAs were to their neighboring mRNAs. C Histograms of
exon counts for mRNA or lncRNA/TUCP transcripts. D Histograms of
number of unique isoforms for each mRNA or lncRNA/TUCP gene. E
Cumulative distributions of mean exonic PhastCons conservation scores
for mRNAs or lncRNAs/TUCPs. All lncRNAs/TUCPs were less conserved
than mRNAs, but were more conserved than repeat regions. Left panels
represent results using polyA RNA data, right panels represent results
using total RNA data. (PDF 211 kb)
Additional file 6: Table S4. Related to Fig. 2a. Expression table of all
bulk tissue samples and differentially expressed genes, using polyA data.
Expression values are in TPM (Transcripts per Million). (XLS 336 kb)
Additional file 7: Figure S3. Identification of lncRNAs enriched in total
RNA-seq. Smooth scatter plot comparisons of mRNA (left) and lncRNA
(right) expression levels between polyA RNA-seq and total RNA-seq in all
eight samples. Genes not expressed either polyA or total RNA-seq were
omitted. Fifty-eight mRNAs and 85 lncRNAs were consistently >10-fold
enriched in total RNA-seq across all samples. Only one gene, NDUFC2-
KCTD14, was identified as consistently enriched in the polyA selected
RNA-seq. Red diagonals represent 10-fold enrichment in either total
(upper) or polyA (lower) fractions. Red triangles represent histone subunits
enriched >10-fold in total RNA. TPM, Transcripts per Million. (PDF 1053 kb)
Additional file 8: Table S5. Related to Fig. 2c. Expression table of all
bulk tissue samples showing genes enriched in either total RNA-seq or
polyA RNA-seq. Both polyA and total RNA-seq data are represented for
each tissue sample. Expression values are in TPM (Transcripts per Million).
(XLS 58 kb)
Additional file 9: Figure S4. Summary statistics and quality control of
single-cell RNA-seq. A Distribution of numbers of genes detected in each
of the 276 neocortex single cells analyzed. The >1000 genes detected
threshold was selected due to rapid decay of complexity below 1000 genes,
potentially due to failed lysis of some cells. B Distribution of numbers of ERCC
species detected in each of the 276 neocortex single cells analyzed. The set
of cells at 0 ERCCs represents single cell libraries previously sequenced and
analyzed in Pollen et al. [32], which lack ERCCs. C Number of reads mapping
to genes (red) and ERCC species (blue) in each of the 276 neocortex single
cells. D Identification of highly variable genes (red; FDR <0.05; Chi-squared
distribution) used for cell type inference by modeling technical noise of ERCC
Spike-In Controls (blue circles). Blue curve represents a gamma generalized
linear model relating the coefficients of variation squared for ERCCs as a
function of mean normalized counts. Dotted red curve represents 50 %
biological variance above technical noise. E Detection rate of ERCC Spike-In
Control RNA at predetermined quantities of spikes across 226 neocortex
single cells. Red dotted line represents 74 % mean detection rate at two copies
per cell. F Linear regression model relating size factor normalized counts to
ERCC molecule quantity. G Detection rate of ERCC Spike-In Control RNA
at predetermined quantities of spikes across 46 K562 single cells. Red
dotted line represents 62 % mean detection rate at two copies per cell.
H Linear regression model relating normalized counts to ERCC mol-
ecule quantity in K562 cells. I Transcript lengths of lncRNAs (blue) and
mRNAs (red). Median lncRNA length was 0.40-fold that of median mRNA
length. The omission of length normalization in single-cell data there-
fore does not artificially overestimate lncRNA abundance. J Pearson cor-
relation coefficients between ERCC molecule quantity and various
expression metrics in 46 K562 single cells. CPM, Counts per Million
mapped reads; FPKM, Fragments per Kilobase per Million mapped
reads; TPM, Transcripts per Million. Count based metrics (Counts, CPM)
outperformed length-normalized metrics (FPKM, TPM) in single-cell
RNA-seq data prepared using the SMARTer method. (PDF 219 kb)
Additional file 10: Table S6. Related to Fig. 3. Single cell expression
table. A total of 276 single cells from human neocortex development and
all genes (including known and novel lncRNAs) that pass the minimum
expression threshold (Methods). Expression values are in size factor
normalized counts, according to DESeq. (XLS 31786 kb)
Additional file 11: Figure S5. Expression of lncRNAs and mRNAs in
single cells and whole tissues. A Distributions of non-zero lncRNA (blue)
and mRNA (red) expression in 276 single cells from neocortex. The median
lncRNA expression and the median mRNA expression for each cell was
compared as a ratio and summarized in Fig. 3b. B Distributions of non-zero
lncRNA (blue) and mRNA (red) expression in eight bulk tissue RNA-seq
samples using the same set of 1400 lncRNAs and 10929 mRNAs as in (A).
C Distributions of non-zero lncRNA (blue) and mRNA (red) expression in in
silico merged neocortex single cells. D Proportion of single neocortex cells
that expressed each lncRNA (blue) and mRNA (red), binned by their
expression levels in bulk tissues. E Distributions of housekeeping
gene and lncRNA (F) expression levels in neocortex single cells,
binned by log2(Normalized Counts + 1). Colors represent number of
cells in each bin. Abundant lncRNAs were ranked by their median
expression levels across 276 neocortex single cells. (PDF 257 kb)
Additional file 12: Figure S6. Single cell transcriptomics of lncRNA
expression in K562 cell cultures. A Distributions of median lncRNA
expression to median mRNA expression ratios (lncRNA:mRNA) in
populations, in silico merged single cells, and single cells from K562
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cultures. B Proportion of K562 cells that expressed each lncRNA (blue)
and mRNA (red), separated by maximum expression in single cells. C Same
as in (B) but grouped by maximum expression quantile. D Distributions of
non-zero lncRNA (blue) and mRNA (red) expression in 46 single K562 cells.
Green squares, housekeeping genes; black triangles, ERCC Spike-In Controls.
(PDF 454 kb)
Additional file 13: Figure S7. Hierarchical clustering of neocortex
single cells. Results of complete linkage hierarchical clustering of 276
neocortex single cells, using the top 500 genes ranked by the highest
absolute values of gene loading scores across the first four principal
components following PCA. Endo, endothelial; RG, radial glia; DRG,
dividing radial glia; IPC, intermediate progenitor cell; NN, newborn
neurons; MN, maturing neurons; INTER, interneurons. (PDF 51 kb)
Additional file 14: Table S7. Related to Fig. 4. Table of 105 cell type-
specific mRNAs (1st tab) and lncRNAs (2nd tab) and their expression
enrichment scores, which are log2 transformed, for each of the seven
cell type clusters. (XLS 42 kb)
Additional file 15: Figure S8. Abundant expression of cell type-specific
lncRNAs in single cells. A Distributions of expression levels of cell type-
specific mRNAs and (B) lncRNAs in single neocortex cells, binned by
log2(Normalized Counts + 1). Heatmap colors represent number of cells
in each bin. Genes were ranked by their median expression levels across
276 neocortex single cells. Columns adjacent to gene names represent
cell type assignments. C Distributions of maximum log odds ratios for cell
type-specific gene expression at 75%ile threshold for each lncRNA (blue) and
mRNA (red) at different quantiles of expression. D Cumulative distributions of
cell type specificity scores for lncRNAs expressed at various levels in bulk
tissues. Endo/red, endothelial; RG/blue, radial glia; DRG/green, dividing radial
glia; IPC/purple, intermediate progenitor cell; NN/orange, newborn neurons;
MN/yellow, maturing neurons; INTER/brown, interneurons. (PDF 120 kb)
Additional file 16: Figure S9. Gene co-expression analysis of cell type-
specific lncRNAs in single cells. A Matrix of Pearson correlation coefficients
between cell type-specific lncRNAs and the top 10 % most correlated or
anticorrelated mRNAs across single cells. B Gene ontology terms for gene
clusters identified in the correlation matrix. Cluster nodes are labeled with
red circles. Header bar colors for lncRNAs: red, endothelial; blue, radial glia;
green, dividing radial glia; purple, intermediate progenitor cell; orange,
newborn neurons; yellow, maturing neurons; brown, interneurons.
(PDF 211 kb)
Additional file 17: Figure S10. Immunohistochemistry of maturing
neuron marker ADRA2A. Immunohistochemistry of maturing neuron marker
protein ADRA2A (left) compared to in situ hybridization against maturing
neuron lncRNA LINC00599 (right, reproduced from Fig. 5). (PDF 952 kb)
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